Gilead Sciences (GIS.DE) Stock Price

€100.8 0%

Sign up
to add to portfolio

AI Score

Hold

  • Alternative

    7

  • Fundamental

    8

  • Technical

    6

Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.

Sign up to get access to more historical data and insights on Gilead Sciences, AI stock picks, stock alerts and much more.

Sign up

GIS.DE AI Stock Analysis

AI stock analysis for GIS.DE is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Gilead Sciences (GIS.DE) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

Gilead Sciences (GIS.DE) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Gilead Sciences (GIS.DE), currently trading at €100.8, will... Sign up to access price prediction.

Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.

About GIS.DE

LSE

  • Gilead Sciences, Inc.

  • Symbol

    GIS.DE

  • Market

    XETRA

  • Industry

    Drug Manufacturers - General

  • Market Cap

    125.1B

Similar Stocks

PFE.F Pfizer Inc.
PFE.F		 €21.97
1%
5
AMG.DE Amgen Inc.
AMG.DE		 €251.6
2.3%
6
ZEG.DE AstraZeneca PLC
ZEG.DE		 €138.4
0.7%
7
PFE.DE Pfizer Inc.
PFE.DE		 €22.11
0.7%
5
IDP.DE Biogen Inc.
IDP.DE		 €119.8
0.3%
7

News

Gilead Sciences Stock Slips After Mixed Q1 Results, Lowered FY25 EPS Guidance

Gilead Sciences Stock Slips After Mixed Q1 Results, Lowered FY25 EPS Guidance
April 24, 2025. Biztoc.com
Gilead Sciences' Bread-And-Butter Drug Missed Sales Views. And It's Not The Only One

Gilead Sciences' Bread-And-Butter Drug Missed Sales Views. And It's Not The Only One
April 24, 2025. Biztoc.com
Brokerages Set Gilead Sciences, Inc. (NASDAQ:GILD) Price Target at $105.12

Brokerages Set Gilead Sciences, Inc. (NASDAQ:GILD) Price Target at $105.12
April 23, 2025. ETF Daily News
P/E Ratio Insights for Gilead Sciences

P/E Ratio Insights for Gilead Sciences
April 23, 2025. Biztoc.com

GIS.DE Alternative Data

Web Traffic

Gilead Sciences receives an estimated 658707 monthly visitors to gilead.com.

  • Web Traffic

    658707

  • Change from Previous Month

    1.7%

  • 3 Month Change

    7%

  • YoY Change

    7%

Twitter Followers

Gilead Sciences has 72,995 Twitter Followers on its main Twitter (also known as X) account, which is up by 0% over the last month.

  • Twitter Followers

    72995

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0.5%

  • YoY Change

    0.5%

Facebook Engagement

Gilead Sciences has engaged 83 users via their Facebook Page over the last 7 days.

  • Facebook Engagement

    83

  • Daily Change

    5.1%

  • 1 Month Change

    48.8%

  • 3 Month Change

    29.1%

  • YoY Change

    29.1%

Instagram Followers

Gilead Sciences has 15,405 Instagram Followers on its main Instagram account, up by 2.9% over the last month.

  • Instagram Followers

    15405

  • Daily Change

    0.1%

  • 1 Month Change

    2.9%

  • 3 Month Change

    9.7%

  • YoY Change

    9.7%

Youtube Subscribers

Gilead Sciences has 5,850 subscribers on its main Youtube channel, up by 0.5% over the last month.

  • Youtube Subscribers

    5850

  • Daily Change

    0%

  • 1 Month Change

    0.5%

  • 3 Month Change

    2.1%

  • YoY Change

    2.1%

Job Postings

Gilead Sciences has an estimated 310 open job postings, which is down -3.1% over the last month.

  • Job Postings

    310

  • Daily Change

    0%

  • 1 Month Change

    3.1%

  • 3 Month Change

    9.4%

  • YoY Change

    9.4%

Reddit Mentions

Gilead Sciences has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

LinkedIn Followers

727,078 are following Gilead Sciences on LinkedIn, up by 1.6% over the last month.

  • LinkedIn Followers

    727078

  • Daily Change

    1.6%

  • 1 Month Change

    1.6%

  • 3 Month Change

    4.6%

  • YoY Change

    4.6%

LinkedIn Employees

According to LinkedIn, Gilead Sciences has 14,637 employees, down by -0.1% over the last month.

  • LinkedIn Employees

    14637

  • Daily Change

    0.1%

  • 1 Month Change

    0.1%

  • 3 Month Change

    1.1%

  • YoY Change

    1.1%

Business Outlook

According to employee reviews, the business outlook among employees at Gilead Sciences is 54 out of 100 (neutral).

  • Business Outlook

    54

  • Change from Previous Month

    1.9%

  • 3 Month Change

    3.8%

  • YoY Change

    3.8%

News Mentions

Gilead Sciences was mentioned 8 times in the news yesterday.

  • News Mentions

    8

  • Daily Change

    60%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

GIS.DE Financials

GIS.DE Key Metrics

  • Total Revenue

    $0

  • Net Income

    $0

  • Earnings per Share

    $1.06

  • Free cash flow

    $2.8B

  • EBITDA

    $0

  • EBITDA Ratio

    0

  • Total Assets

    $59B

GIS.DE 2-year Revenue & Income
GIS.DE 2-year Free Cash Flow

GIS.DE Technicals

GIS.DE SMA
GIS.DE RSI

FAQ

What's the current price of Gilead Sciences (GIS.DE) Stock?
The price of an Gilead Sciences (GIS.DE) share is €100.8.

What's the market cap of Gilead Sciences?
The current market cap of Gilead Sciences is 125.1B.

Should I buy or sell GIS.DE?
Multiple alternative data signals suggest that Gilead Sciences stock could offer a buying opportunity at its current level, with a reasonable expectation for positive performance in the mid term.

Is Gilead Sciences a good investment?
Based on an in-depth analysis that encompasses fundamentals, technical analysis, and alternative data insights, it appears to be a favorable time to consider investing in Gilead Sciences stock. The bullish indicators suggest that Gilead Sciences' growth prospects and market position may lead to a positive performance in the foreseeable future.

Is now a good time to buy Gilead Sciences (GIS.DE) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it could be a favorable time to consider buying Gilead Sciences stock, given the bullish outlook.

What are some stocks similar to Gilead Sciences (GIS.DE) that investors often compare it to?
Gilead Sciences (GIS.DE) is often compared to similar stocks such as Pfizer Inc., Amgen Inc., AstraZeneca PLC, Pfizer Inc. and Biogen Inc..

What is the forecast for Gilead Sciences' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Gilead Sciences' stock price to be around €108 in 2026. Starting from the current price of €100.8, this represents a 7.1% change in price, indicating a bullish outlook for the stock.

How to buy Gilead Sciences (GIS.DE) Stock?
Gilead Sciences stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Gilead Sciences shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.